The Nebulizer Market is expected to foresee significant growth. The U.S. to lead the growth!

The nebulizer market is expected to witness a CAGR of around 7% during the forecast period. A nebulizer is a piece of medical equipment that can help patients to breathe the medicine directly into the lungs and the respiratory system through a mask or a mouthpiece. Nebulizers are used by patients in severe conditions of the patient and if the patient can’t use an inhaler. Moreover, nebulizers are becoming more popular and expanding at a rapid rate owing to the introduction of technologically advanced products by key players coupled with increasing cases of asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD), lung cancer, and other respiratory disorders. Furthermore, the rising geriatric population is also a key factor propelling the market growth during the forecast period. For instance, according to the World Population Ageing Report 2019 by United Nations (UN), In 2019, there were 703 million persons aged 65 years or over in the global population. This number is projected to double to 1.5 billion in 2050.
For a detailed analysis of the nebulizer market browse throughhttps://univdatos.com/report/nebulizer-market/

Based on product, the nebulizer market is segmented into jet nebulizers, mesh nebulizers, and ultrasonic nebulizers. In 2020, the jet nebulizers category is anticipated to witness a significant growth rate during the forecast period. In addition, jet nebulizers are cost-effective, easy to use, and effective in delivering drugs that cannot be delivered with pMDIs and DPIs. In addition, the growth of this segment is mainly due to increasing cases of chronic obstructive pulmonary disease (COPD), respiratory disease, and the increasing geriatric population. For instance, according to the institute for Health Metrics and Evaluation (IHME), chronic respiratory diseases were responsible for 71·1 million YLLs and 32·4 million YLDs in 2019. Chronic Obstructive Pulmonary Disease (COPD) and asthma were the two largest contributors to the global respiratory disease burden.

Based on modality, the nebulizer market is segmented into portable and table-top. In 2020, the portable category is anticipated to witness a significant growth rate during the forecast period. Portable nebulizer devices offered some features including being easy to use at home because of their small size and affordability which are likely to increase the market growth. In addition, the growing number of players in the launching of portable devices and their rising adoption are likely to significantly boost the portable category growth during the forecast period. For instance, Omron Healthcare launched a new portable nebulizer “OMRON NE C106” in 2020.

Based on end-user, the nebulizer market is categorized into hospitals & clinics, ambulatory & emergency centers, and home care settings. In 2020, the hospitals & clinics category dominated the market and is expected to grow significantly in the upcoming years. Mainly due to the increasing construction of hospitals with a major number of patients treated at hospitals due to the availability of skilled professionals in the hospitals. In addition, the surge in the cases and the first level of diagnosis and treatment of patients of asthma, cystic fibrosis, bronchiectasis, and respiratory cases in hospitals & clinics are the major factors for the growth of this category during the forecast period.

Request for Sample of the report browse throughhttps://univdatos.com/get-a-free-sample-form-php/?product_id=22726

For a better understanding of the market, the report provides a detailed analysis of major regions and countries including North America (U.S., Canada, Rest of North America); Europe (Germany, U.K., France, Spain, Italy, Rest of Europe); Asia-Pacific (China, India, Japan, Australia, Rest of Asia-Pacific) and Rest of World. In 2020, North America accounted for a significant market share. This is mainly due to the increased lung and respiratory diseases and rising geriatric population coupled with advanced healthcare infrastructure and the adoption of new medical devices are the major factors for the growth of the market in this region.

Some of the major companies operating in Nebulizer include Briggs Medical Service Company, Besco Medical, Flyp Nebulizers, DeVilbiss Healthcare International, Omron Corporation, Becton, Dickinson and Company, Feellife Health Inc., Pari Medical Ltd., Philips Respironics, Inc., and Graham Field (GF) Health Products, Inc.

Nebulizer Market Segmentation

Market Insight, by Product

• Jet Nebulizer
• Mesh Nebulizer
• Ultrasonic Nebulizer

Market Insight, by Modality

• portable
• Table-top

Market Insight, by End-User

• Hospitals & clinics, ambulatory
• Emergency centers• Homecare settings

Market Insight, by Region

• North America Nebulizer
  • U.S.
  • Canada
  • Rest of North America
• Europe Nebulizer
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia-Pacific Nebulizer
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
• Rest of the world Nebulizer

Top Company Profiles

• Briggs Medical Service Company
• Besco Medical
• Flyp Nebulizerss
• Drive DeVilbiss International
• Omron Healthcare, Inc.
• Becton, Dickinson and Company
• FEELLiFE HEALTH INC
• PARI Pharma GmbH
• Respironics, Inc.
• GF Health Products, Inc.